All In Biotech

Drug Trial Radar · NCT07182864

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

Phase I/II Study of MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Sep 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

160

Actual

Start

Jan 6, 2022

Primary completion

Sep 8, 2022

Study completion Oct 8, 2022

Sponsor

Sponsor type
Industry
First posted
Sep 19, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.

Conditions

  • Atopic Dermatitis (AD)

Interventions

  • MH004 0.1% OintmentDrug

    MH004 0.1% ointment applied topically to the affected area as a thin film.

  • MH004 0.3% OintmentDrug

    MH004 0.3% ointment applied topically to the affected area as a thin film.

  • MH004 1.0% OintmentDrug

    MH004 1.0% ointment applied topically to the affected area as a thin film.

  • MH004 3.0% OintmentDrug

    MH004 3.0% ointment applied topically to the affected area as a thin film.

  • Vehicle OintmentDrug

    Matching vehicle ointment applied topically to the affected area as a thin film.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase I: Incidence and severity of Treatment-Emergent Adverse Events (Safety and Tolerability)Time frame: 1 year
  2. Phase II: Mean Percentage Change From Baseline in EASI Score at Week 4 in Participants Treated With MH004 OintmentTime frame: Baseline and week 4.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Huashan Hospital Affiliated to Fudan University

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.